Skip to main content
. 2020 Dec 25;37(6):1012–1024. [Article in Chinese] doi: 10.7507/1001-5515.202009083

表 4. Global research hotspots on oncology: respiratory system and breast cancer.

肿瘤领域全球研究热点——呼吸系统与乳腺肿瘤

研究主题 相关研究 被引次数
查询时间
2020.09.23
期刊来源
呼吸系统肿瘤
临床试验 Five-year follow-up of nivolumab in previously treated advanced non-small-cell lung cancer:results from the CA209-003 study[27] 204 J Clin Oncol
Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma(KEYNOTE-028):preliminary results from a non-randomised,open-label,phase 1b trial[28] 195 Lancet Oncol
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA(N1-N2) EGFR-mutant NSCLC(ADJUVANT/CTONG1104):a randomised,open-label,phase 3 study[29] 140 Lancet Oncol
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer(ATLANTIC):an open-label,single-arm,phase 2 study[30] 170 Lancet Oncol
PD-L1 免疫组化 Agreement between programmed cell death ligand-1 diagnostic assays across multiple protein expression cutoffs in non-small cell lung cancer[31] 170 Clin Cancer Res
肺癌脑转移预后评估分级 Estimating survival in patients with lung cancer and brain metastases:an update of the graded prognostic assessment for lung cancer using molecular markers(Lung-molGPA)[32] 179 JAMA Oncol
非小细胞肺癌临床和分子特征 Clinical and molecular characteristics associated with survival among patients treated with checkpoint inhibitors for advanced non-small cell lung carcinoma:
a systematic review and meta-analysis[33]
134 JAMA Oncol
乳腺肿瘤
乳腺癌 Effect of axillary dissection vs no axillary dissection on 10-Year overall survival among women with invasive breast cancer and sentinel node metastasis:the ACOSOG Z0011(Alliance) randomized clinical trial[34] 299 JAMA
Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer[35] 447 N Engl J Med
Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer[36] 388 N Engl J Med
Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer[37] 453 JAMA
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer:a pooled analysis of 3771 patients treated with neoadjuvant therapy[38] 292 Lancet Oncol
乳房植入物 Breast implants and the risk of anaplastic large-cell lymphoma in the breast[39] 109 JAMA Oncol